HIV-1 has evolved multiple mechanisms to elude immune control. The view of virus as
classifiable into distinct subtypes needs to reflect the reality of the constant emergence of …

During the extended clinically latent period associated with Human Immunodeficiency Virus
(HIV) infection the virus itself is far from latent. This phase of infection generally comes to an …

Abstract Background. In Thailand, phase 1/2 trials of monovalent subtype B and bivalent
subtype B/E (CRF01_AE) recombinant glycoprotein 120 human immunodeficiency virus …

We have devised a simple enzyme immunoassay (EIA) that detects increasing levels of anti-
HIV IgG after seroconversion and can be used for detecting recent HIV-1 infection. Use of a …

HIV-1 genetic variability within individuals and populations plays a central role in the HIV
pandemic. Multiple zoonotic transmissions of SIV to humans have resulted in distinct HIV …

The effect of human immunodeficiency virus (HIV) type 1 envelope subtypes A and D on
disease progression was investigated in 1045 adults in Uganda. At enrollment and every 6 …

Background Our intention was to compare the rate of immunological progression prior to
antiretroviral therapy (ART) and the virological response to ART in patients infected with …

Superinfection with multiple strains or subtypes of the human and simian immunodeficiency
viruses has been documented. Recent increases in the prevalences of both unprotected …

The global spread of human immunodeficiency virus (HIV) and the human suffering left in its
wake have made AIDS a global heath priority. Yet the capacity of HIV to mutate and evolve …

Background: The molecular epidemiology of the HIV-1 CRF01_AE subtype as a risk factor
for fast HIV-1 progression remains poorly understood. Methods: We analyzed HIV-1 tropism …